Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
Contacts and Locations
No Study Results Posted
Related Studies
Safety and Efficacy of a Three-Dose Regimen of an Adenoviral HIV Vaccine (MRKAd5 HIV-1 Gag/Pol/Nef) in HIV Uninfected South African Adults
This study has been suspended.
Study NCT00413725. Last updated on May 16, 2008.
Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV Infections
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
Infection
More general conditions related to this trial
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Virus Diseases
Interventions listed in this trial
MRKAd5 HIV-1 gag/pol/nef
Placebo
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)
HIV Vaccine Trials Network
Back to top of Main Content